This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Simsic, J. M. Articles by Michler, R. E. Search for Related Content PubMed PubMed Citation Articles by Simsic, J. M. Articles by Michler, R. E. Social Bookmarking                         What's this?

Perioperative Effects and Safety of Nesiritide Following Cardiac Surgery in Children

Heart Care International, Santo Domingo, Dominican Republic; Sibley Heart Center Cardiology, The McGill Building, 2835 Brandywine Road, Suite 300, Atlanta, GA 30341; simsicj{at}kidsheart.com

Mark Scheurer, MD

Heart Care International, Santo Domingo, Dominican Republic; Division of Pediatric Cardiology, Medical University of South Carolina, Charleston, SC

Joseph D. Tobias, MD

Heart Care International, Santo Domingo, Dominican Republic; Division of Pediatric Anesthesiology/Pediatric Critical Care, University of Missouri, Columbia, MO

John Berkenbosch, MD

Heart Care International, Santo Domingo, Dominican Republic; Division of Pediatrics/Pediatric Critical Care, University of Louisville, Louisville, KY

William Schechter, MD

Heart Care International, Santo Domingo, Dominican Republic; Department of Anesthesiology, Columbia University, New York, NY

Freddie Madera, MD

Heart Care International, Santo Domingo, Dominican Republic

Samuel Weinstein, MD

Robert E. Michler, MD

Heart Care International, Santo Domingo, Dominican Republic; Department of Cardiothoracic Surgery, Montefiore Medical Center, Bronx, NY

Nesiritide (Natrecor, Scios Inc), human B-type natriuretic peptide, has hemodynamic effects that may be beneficial in pediatric patients after cardiac surgery. Experience with nesiritide and pediatrics is limited. The purpose of this study was to evaluate perioperative effects and safety of nesiritide in pediatric cardiothoracic surgery. Seventeen patients with congenital heart disease undergoing cardiac surgery were given a loading dose (1 µg/kg) while on cardiopulmonary bypass (constant flow) followed by continuous infusion for 24 hours (0.01 µg/kg/min x 6 hours, then 0.02 µg/kg/min x 18 hours). A 7% decrease in mean blood pressure was seen following nesiritide loading dose on cardiopulmonary bypass. No patient required intervention for hypotension while receiving nesiritide load or infusion. Nesiritide load during surgery and continuous infusion after cardiac surgery in pediatric patients resulted in no significant hemodynamic compromise.

Key Words: B-type natriuretic peptide • cardiac surgery • congenital heart disease • pediatrics

References

• Abraham WT, Lowes BD, Ferguson DA, et al. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail. 1998;4:37-44.[Medline] [Order article via Infotrieve]
• Holmes SJ, Espiner EA, Richards AM, Yandle TG, Frampton C. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab. 1993;76:1004-1009.
• Marcus LS, Hart D, Packer M, et al. Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure: a doubleblind, placebo-controlled, randomized cross-over trial. Circulation. 1996;94:3184-3189.[Abstract/Free Full Text]
• Mills RM, LeJemtel TH, Horton DP, et al. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, doubleblinded, placebo-controlled clinical trial. J Am Coll Cardiol. 1999;34:155-162.[Abstract/Free Full Text]
• Marshall J, Berkenbosch JW, Russo P, Tobias JD. Preliminary experience with nesiritide in the pediatric population. J Intensive Care Med. 2004;19:164-170.[Abstract/Free Full Text]
• Simsic JM, Reddy VS, Kanter KR, Kirshbom PM, Forbess JM. Use of nesiritide (human B-type natriuretic peptide) in infants following cardiac surgery. Pediatr Cardiol. 2004;25:668-670.[CrossRef][Medline] [Order article via Infotrieve]
• Lehot JJ, Villard J, Piriz H, et al. Hemodynamic and hormonal responses to hypothermic and normothermic cardiopulmonary bypass. J Cardiothorac Vascular Anesth. 1992;6:132-139.
• Maisel AS, Koon J, Krishnaswamy P, et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J. 2001;141:367-374.[CrossRef][Medline] [Order article via Infotrieve]
• Wernovsky G, Wypij D, Jonas RA, et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation. 1995;92:2226-2235.[Abstract/Free Full Text]
• Wessell DL, Aditia I, Giglia TM, Thompson JE, Kulik TJ. Use of nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation. 1993;88:2128-2138.[Abstract/Free Full Text]
• Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998;339:321-328.[Free Full Text]
• Yoshimura N, Yamaguchi M, Oshima Y, et al. Suppression of the secretion of atrial and brain natriuretic peptide after total cavopulmonary connection. J Thorac Cardiovasc Surg. 2000;120:764-769.[Abstract/Free Full Text]
• Costello JM, Backer CL, Checchia PA, Mavroudis C, Seipelt RG, Goodman DM. Alterations in the natriuretic hormone system related to cardiopulmonary bypass in infants with congestive heart failure. Pediatr Cardiol. 2004;25:347-353.[Medline] [Order article via Infotrieve]
• Publication committee for VMAC investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA. 2002;287:1531-1540.[Abstract/Free Full Text]
• Koller KJ, Goeddel DV. Molecular biology of the natriuretic peptide and their receptors. Circulation. 1992;86:1081-1088.[Abstract/Free Full Text]
• Maack T. Receptors of atrial natriuretic factor. Ann Rev Physiol. 1992;54;11-27.[CrossRef][Medline] [Order article via Infotrieve]

Journal of Intensive Care Medicine, Vol. 21, No. 1, 22-26 (2006)
DOI: 10.1177/0885066605282532


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. Shekerdemian Perioperative manipulation of the circulation in children with congenital heart disease Heart, August 1, 2009; 95(15): 1286 - 1296. [Full Text] [PDF]

				A. Ryan, D. A. Rosen, and J. D. Tobias Preliminary Experience With Nesiritide in Pediatric Patients Less Than 12 Months of Age J Intensive Care Med, September 1, 2008; 23(5): 321 - 328. [Abstract] [PDF]

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Simsic, J. M. Articles by Michler, R. E. Search for Related Content PubMed PubMed Citation Articles by Simsic, J. M. Articles by Michler, R. E. Social Bookmarking                         What's this?